Ensuring the Quality of Molecular Genetic Testing in Healthcare Delivery Systems: Promoting Effective Reporting and Use of Test Results for Clinical Decision Making

The summary for the Ensuring the Quality of Molecular Genetic Testing in Healthcare Delivery Systems: Promoting Effective Reporting and Use of Test Results for Clinical Decision Making Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Ensuring the Quality of Molecular Genetic Testing in Healthcare Delivery Systems: Promoting Effective Reporting and Use of Test Results for Clinical Decision Making
	CFDA Number:	93.064
	CFDA Description:	Laboratory Training, Evaluation, and Quality Assurance Programs
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	CDC-RFA-CI10-1005
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	May 17, 2010
	Creation Date:	May 17, 2010
	Original Closing Date for Applications:	Jul 07, 2010
	Current Closing Date for Applications:	Jul 07, 2010
	Archive Date:	Aug 06, 2010
	Expected Number of Awards:	1
	Estimated Total Program Funding:	$1,500,000
	Federal Grant Award Ceiling:	$500,000
	Federal Grant Award Floor:	$300,000
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible applicants that can apply for this funding opportunity are listed below: Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) Universities Colleges Research institutions Hospitals Community-based organizations Faith-based organizations Federally recognized or state-recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov.
Grant Description: Purpose: The intent of the RFA is to provide funding for the design and implementation of a pilot project to evaluate the previously developed clinician-friendly molecular genetic test report format and other principles established in previous work supported by the CDC (J Mol Diagn 2009;11:162-171; J Mol Diagn 2008:10:459-468) to determine whether changes in clinical and laboratory practices are likely to improve the quality of patient care within a targeted healthcare delivery system. A healthcare delivery system can refer to a fee-for-service network, health maintenance organization, academic medical center with outreach clinics, or similar entities with a diverse but defined patient population. Specified genetic conditions for which clinical molecular testing is available will be chosen as models in carrying out the work proposed.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Center for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700

PGOTIM@cdc.gov [PGOTIM@cdc.gov]
Similar Government Grants: • Improving Rapid Influenza Testing Practices in Outpatient Settings: Evidence-Based Solutions; • Evidence-Based Laboratory Medicine: Quality/Performance Measure Evaluation; • Integration of ISO and Quality Management System Standards into National Public Health Laboratory Ne...; • Evaluation of Current Practices in Reporting Gynecologic Cytology Test Results and Cytology Proficie...; • Improvement of Laboratory Testing and Services in the United States; • Initiative to Integrate Clinical Laboratories into Public Health Testing; • Developing an Agenda for Laboratory Practice Research Based on the 2007 Institute: Managing for Bett...; • Evidence Based Laboratory Medicine: Qualtiy/Performance Measure Evaluation; • Evaluation of the Use of Rapid Testing For Influenza in Outpatient Medical Settings